HCW Biologics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. HCW Biologics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 58% to $2,841,794. Profit margin reached -880%. Total operating expenses were $26,277,520.
Profit Margin
| 2019 | 0 | -7.22M | |
|---|---|---|---|
| 2020 | 4.09M | -5.77M | -140.98% |
| 2021 | 0 | -12.35M | |
| 2022 | 6.72M | -14.72M | -219.02% |
| 2023 | 2.84M | -24.99M | -879.52% |
HCWB Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 2.84M | 6.72M | 0 | 4.09M | 0 |
Cost of revenue | 2.28M | 4.13M | 543.59K | 0 | 421.81K |
Gross profit | 560.36K | 2.58M | -543.59K | 4.09M | -421.81K |
Operating exp. | |||||
Research and development | 7.67M | 9.33M | 8.17M | 7.25M | 5.39M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 26.27M | 17.66M | 13.36M | 9.92M | 7.36M |
Operating income | -25.71M | -15.07M | -13.36M | -5.82M | -7.36M |
Other income (expenses), net | 722.88K | 178.07K | 505.36K | 22.32K | 72.35K |
Income before tax | -24.99M | -14.90M | -12.86M | -5.80M | -7.29M |
Income tax expense | 0 | -178.07K | -505.36K | -22.32K | -72.35K |
Net income | -24.99M | -14.72M | -12.35M | -5.77M | -7.22M |
Earnings per share | |||||
Basic EPS | -0.7 | -0.41 | -0.35 | -0.16 | -0.2 |
Diluted EPS | -0.7 | -0.41 | -0.35 | -0.16 | -0.2 |
| Data source | Data source | Data source |